Prolonged Protocol of Early Follicular or Mid Luteal Phase
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- IVF
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: The early follicular and mid luteal prolonged regimens were randomly enrolled in a ratio of 1 to 1Masking: Single (Investigator)Masking Description: Statistician blindnessPrimary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 42 years
- Gender
- Only males
Description
One injection of 3.75mg GnRHa was injected on the 1st-3rd or 21st-23rd day of menstruation. The level of estradiol (E2), progesterone (P), luteinizing hormone (LH) in peripheral blood and the number of follicles in bilateral ovarian internal sinuses were monitored on the 32nd-38th day after pituitar...
One injection of 3.75mg GnRHa was injected on the 1st-3rd or 21st-23rd day of menstruation. The level of estradiol (E2), progesterone (P), luteinizing hormone (LH) in peripheral blood and the number of follicles in bilateral ovarian internal sinuses were monitored on the 32nd-38th day after pituitary hyporegulation.Gonadotropin (Gn) will be given after pituitary desensitization. When the diameter of at least two follicles ? 18mm or more than three follicles ? 17mm, the trigger of human chorionic gonadotropin (hCG) will be given and oocyte will be retrieved. The selective fresh single blastocyst transplantation will be carried out on the 4th-6th day after oocyte retrieval. HCG test at 12nd day after transplatation. Follow-up investigation will given during the pregnancy and perinatal period.
Tracking Information
- NCT #
- NCT04522479
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Yingfen Ying The 2nd Affiliated Hospital of Wenzhou Medical University
Get Well Soon